Vaccines and DNA Sequencing Led European Biotech Investments in May
Last month saw huge biotech investment rounds dedicated to Covid-19 vaccines in Europe, including IPOs…
10/06/2021 - 4 minutes
Trends & News
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
08/06/2021 - 5 minutes
Biotech Investment Firms Intensify Funding Spree After 2020 Surge
Two big closings last month by Ysios Capital in Spain and Abingworth in the UK…
03/06/2021 - 6 minutes
Next-Generation mRNA Vaccine Technology Unveiled in Series A Round
Messenger RNA vaccines have been at the forefront of the global struggle against the Covid-19…
01/06/2021 - 4 minutes
Startup Creator Launched to Fill Europe’s Microbiome Translational Gap
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the…
28/05/2021 - 6 minutes
Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
25/05/2021 - 6 minutes
EU Approves Edible Insects for Humans but Roadblocks Remain
Europe is seeing a surge of interest in edible insect farming after an EU vote…
20/05/2021 - 6 minutes
Avantium and Carbios Capitalize on Growing Bioplastics Demand
As the EU phases out a wide range of single-use plastics this year, investor interest…
18/05/2021 - 5 minutes
European AI Drug Discovery Attracting Tech Investor Bets
Exscientia’s latest €434.9M ($525M) financing last month showed investors are still excited by efforts to…
14/05/2021 - 5 minutes
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
11/05/2021 - 7 minutes
Despite Many Candidates, Covid-19 Treatments Lag Behind Vaccines
There’s promising early data on many potential Covid-19 treatments. Yet with vaccines in the spotlight,…
05/05/2021 - 5 minutes
Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
04/05/2021 - 5 minutes
